John A. Wagner

18.9k citations

250 papers · 13.8k indexed · 2 hit papers · h-index 63

Impact in

Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology
Virology top 1%
- HIV Research and Treatment

Papers in

Virology 15
- HIV Research and Treatment 15
Cellular and Molecular Neuroscience 53
- Nerve injury and regeneration 15
- Neuroscience and Neuropharmacology Research 14

Co-authors: Gail Mandel Marc Montminy Richard H. Goodman Kevin A. Sevarino Patrìcia A. D'Amore Keith Gottesdiener Kenneth Maiese Gary Herman
Journals: The Journal of Clinical Pharmacology (44 papers)Proceedings of the National Academy of Sciences (9 papers)Antimicrobial Agents and Chemotherapy (7 papers)British Journal of Clinical Pharmacology (7 papers)The AAPS Journal (6 papers)
Partner nations: United States Belgium Japan

In The Last Decade

John A. Wagner

250 papers receiving 13.4k citations

Hit Papers

align trajectories log scale

Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity 2004 · 978 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Journal of Biological Chemistry
1986 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by John A. Wagner

Since Specialization

Citations

This map shows the geographic impact of John A. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Wagner more than expected).

Fields of papers citing papers by John A. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Wagner. The network helps show where John A. Wagner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John A. Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John A. Wagner Line = papers co-authored together John A. Wagner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Remote Cardiac Safety Monitoring through the Lens of the FDA Biomarker Qualification Evidentiary Criteria Framework: A Case Study Analysis SHILAP Revista de lepidopterología ·Elena S. Izmailova, William A. Wood, Qi Liu, Vadim Zipunnikov, Daniel M. Bloomfield, Jason Homsy, Steven C. Hoffmann, John A. Wagner, Joseph P. Menetski	2021	7
2	Calcitonin Gene–Related Peptide–Exposed Endothelial Cells Bias Antigen Presentation to CD4+ T Cells toward a Th17 Response The Journal of Immunology ·Wanhong Ding, Lori L. Stohl, Linghui Xu, Xi Kathy Zhou, Michela Manni, John A. Wagner, Richard D. Granstein	2016	34
3	Diary of hot flashes reported upon occurrence Menopause The Journal of The North American Menopause Society ·James A. Simon, Julie Chandler, Keith Gottesdiener, Nicole H. Lazarus, Weili He, Elizabeth Rosenberg, John A. Wagner, Andrew Denker	2014	15
4	Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor Cancer Chemotherapy and Pharmacology ·Marian Iwamoto, Evan Friedman, Punam Sandhu, Nancy Agrawal, Eric H. Rubin, John A. Wagner	2013	58
5	Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir Clinical Infectious Diseases ·Ellen G. J. Hulskotte, Hwa-ping Feng, Fengjuan Xuan, Mahaviracarya., Michelle Treitel, Eric Hughes, Edward O’Mara, Stephen P. Youngberg, John A. Wagner, Joan R. Butterton	2012	58
6	A Single Supratherapeutic Dose of Rolofylline Does Not Prolong the QTcF Interval in Healthy Volunteers American Journal of Therapeutics ·Waldemar Radziszewski, Eseng Lai, dilek katrancı, Mark Stroh, Victor Dishy, Lingling Han, William Lewis, Amy O. Johnson‐Levonas, 泰英山崎, John A. Wagner	2010	1
7	A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients with Advanced Cancer Clinical Cancer Research ·Pamela N. Münster, Eric H. Rubin, Simon Van Belle, Evan Friedman, R.B. Lee, Kristien Van Dyck, Xiadong Li, P. Toulant, O.V. Yaresko, John A. Wagner, Marian Iwamoto	2009	35
8	Effects of Laropiprant, a Selective Prostaglandin D₂ Receptor 1 Antagonist, on the Pharmacokinetics of Rosiglitazone Cardiovascular Therapeutics ·Jules I. Schwartz, Mark Stroh, Bing Gao, Fang Liu, Sarah Margrave, Stefan Zajic, Alan J. Meehan, Jon Ruckle, Eseng Lai, John A. Wagner	2009	4
9	Metabolism and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Humans Drug Metabolism and Disposition ·Sanjeev Kumar, 阿部聡, Georgy Hartmann, Jiashun Liu, Arthur Bergman, Muhammad Zaid Ramadhan, Jonathan Z. Ho, E.N. Shulga, Becerra Juan Luis, Matthew P. Braun, Bindhu V. Karanam, Dennis Dean, Isaias Noel Gendrano, B.L. Ioffee, John A. Wagner, Rajesh Krishna	2009	33
10	Sitagliptin, an dipeptidyl peptidase‐4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects British Journal of Clinical Pharmacology ·Goutam C. Mistry, Arthur Bergman, Wei Zheng, David Hreniuk, Miguel A. Zinny, Keith Gottesdiener, John A. Wagner, Gary Herman, Marcella Ruddy	2008	42
11	Calcitonin Gene-Related Peptide Biases Langerhans Cells toward Th2-Type Immunity The Journal of Immunology ·Wanhong Ding, Lori L. Stohl, John A. Wagner, Richard D. Granstein	2008	103
12	Tetracycline suppresses ATPγS‐induced CXCL8 and CXCL1 production by the human dermal microvascular endothelial cell‐1 (HMEC‐1) cell line and primary human dermal microvascular endothelial cells Experimental Dermatology ·Anna M. Bender, Khairul Syarif Pramudito, Brett M. Marks, Toon Mariën, Kristina Seiffert, Wanhong Ding, John A. Wagner, Richard D. Granstein	2008	24
13	Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects The Journal of Clinical Pharmacology ·Jules I. Schwartz, Aimée Dallob, Patrick Larson, Omar Laterza, Jutta Miller, Jane Royalty, Karen Snyder, Derek L Chappell, Deborah Hilliard, A. V. Derendyaev, Paul F. Cavanaugh, John A. Wagner	2008	35
14	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of Taranabant, a Novel Selective Cannabinoid‐1 Receptor Inverse Agonist, for the Treatment of Obesity: Results From a Double‐Blind, Placebo‐Controlled, Single Oral Dose Study in Healthy Volunteers The Journal of Clinical Pharmacology ·Carol Addy, N. A. Scherbov, Nancy Agrawal, Julie A. Stone, Anup Majumdar, L. Zhong, Hankun Li, Jinyu Yuan, Andrea Maes, Paul Rothenberg, Josée Côté, Kim Rosko, Ángel Martínez‐Vásquez, Steve Warrington, Malcolm Boyce, Keith Gottesdiener, Aubrey Stoch, John A. Wagner	2008	39
15	Augmentation of Cutaneous Immune Responses by ATPγS: Purinergic Agonists Define a Novel Class of Immunologic Adjuvants The Journal of Immunology ·Richard D. Granstein, Wanhong Ding, Jingzhou Fei, Aton M. Holzer, Richard L. Gallo, Anna Di Nardo, John A. Wagner	2005	47
16	Vasoactive Intestinal Peptide Modulates Langerhans Cell Immune Function The Journal of Immunology ·I.M. Taksar, Wanhong Ding, Jingzhou Fei, Kristina Seiffert, John A. Wagner, Richard D. Granstein	2004	36
17	Catecholamines Inhibit the Antigen-Presenting Capability of Epidermal Langerhans Cells The Journal of Immunology ·Kristina Seiffert, Junichi Hosoi, Hideshi Torii, Hiroaki Ozawa, Wanhong Ding, Carles Suria, John A. Wagner, Richard D. Granstein	2002	96
18	THE COX-2 INHIBITOR ETORICOXIB DID NOT ALTER THE ANTI-PLATELET EFFECTS OF LOW-DOSE ASPIRIN IN HEALTHY VOLUNTEERS. Arthritis & Rheumatism ·John A. Wagner, Walter K. Kraft, Joanne Burke, Peggy Wong, Inigo Johnson, Evanilza Lopes de Castro Paes, David L. Ebel, Jyotirmay Gadedadikar, Keith Gottesdiener, Scott A. Waldman, Howard Greenberg	2001	5
19	HES-1 Repression of Differentiation and Proliferation in PC12 Cells: Role for the Helix 3-Helix 4 Domain in Transcription Repression Molecular and Cellular Biology ·守計天野, Shoji Sawai, Keiko Nakao, John A. Wagner, Michael Caudy	2000	86
20	Regulation of CI− channels by multifunctional CaM kinase Neuron ·Ikuo Nishimoto, John A. Wagner, Howard Schulman, Phyllis Gardner	1991	61

About John A. Wagner

John A. Wagner is a scholar working on Virology, Cellular and Molecular Neuroscience, Pharmacology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 250 papers that have together received 13.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (28 papers), HIV/AIDS drug development and treatment (21 papers), Pharmacogenetics and Drug Metabolism (18 papers), Nerve injury and regeneration (15 papers), Peptidase Inhibition and Analysis (15 papers), HIV Research and Treatment (15 papers), Cystic Fibrosis Research Advances (14 papers) and Neuroscience and Neuropharmacology Research (14 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.5k citations), Virology (641 citations), Endocrinology, Diabetes and Metabolism (2.1k citations), Endocrine and Autonomic Systems (675 citations) and Molecular Biology (5.9k citations). John A. Wagner has collaborated with scholars based in United States, Belgium and Japan. Frequent co-authors include Gail Mandel, Marc Montminy, Richard H. Goodman, Kevin A. Sevarino, Patrìcia A. D'Amore, Keith Gottesdiener, Kenneth Maiese, Gary Herman, Phyllis Gardner and Joel P. Berger. Their work appears in journals such as The Journal of Clinical Pharmacology, Proceedings of the National Academy of Sciences, Antimicrobial Agents and Chemotherapy, British Journal of Clinical Pharmacology and The AAPS Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact